CRNX
Crinetics Pharmaceuticals, Inc. · Healthcare
Chief Med, Dev Officer Dana Pizzuti sold $434K of Crinetics Pharmaceuticals, Inc.
Sold$434,435
$45.73Price
9,500Shares
−25%Stake
What CRNX did after the filing
- The stock from Tue, Jun 25 close, $44.87
- +7.6%
- S&P 500, same days
- −4.8%
Measured over 30 trading days, to the Aug 7 close.
Traded Mon, Jun 24. Filed Tue, Jun 25, 1:03 PM ET, during the session. Returns use the Jun 25 close and the Aug 7 close. Not investment advice.